Connection

Jacob Robison to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Jacob Robison has written about Cost-Benefit Analysis.
Jacob Robison
Connection Strength
0.008
Cost-Benefit Analysis
  1. Efficacy of reverse transcriptase-polymerase chain reaction screening for micrometastic disease in axillary lymph nodes of breast cancer patients. Am Surg. 1998 Jun; 64(6):539-43; discussion 543-4.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.